Mid-February 2026 Updates to the European, UK and Swiss Databases and More

By Megan Gottlieb and Evangeline Loh

A multitude of medical device regulators posted updates to their medical device databases in mid-February. 

European EUDAMED

On February 18, EUDAMED Production Hotfix v2.22.2 was deployed. The documentation for v2.22.0 remains valid and included v3 of the European Medical Device Nomenclature (EMDN) Codes.

This is in preparation for the upcoming mandatory use on May 28 of four modules: Actor Registration, UDI/Device Registration, Notified Bodies and Certificates, and Market Surveillance. Of course, Commission Decision 2025/2371 stated that for devices on the market before the May date, the deadline for UDI/Device Registration is November 27. 

UK MHRA PARD

The UK regulator, MHRA, announced on February 20 that the Public Access Registration Database (PARD), is now updated to include brand/trade names. 

Now, in the Advanced Search feature of PARD, users can search by brand/trade names. New information about the use of the Global Medical Device Nomenclature (GMDN) Code was also added, along with information confirming Northern Ireland’s alignment with the EU and EUDAMED. 

Swiss Swissdamed 

Also on February 20, the regulator in Switzerland, Swissmedic, announced the availability of all the technical documentation for Machine to Machine (M2M) registration of devices. The M2M functionality will be available on the Swissdamed platform by the end of March.

The Swissdamed UDI Devices module has been available for voluntary use since August 2025. Mandatory use begins on July 1, 2026. There is an additional grace period to January 1, 2027 for devices on the market before the date of mandatory use. However, after July 1, if a post-market surveillance event (incident, FSCA, trend) occurs, registration in the UDI Devices module becomes immediate.

Earlier in February, Swissmedic also announced the “Legacy Devices” feature is now live in Swissdamed, which enables the registration of legacy devices certified according to the EU MDD, IVDD, or AIMDD.

Brazil SIUD

Normative Instruction nº 426, dated February 13, released the following week, officially launched the UDI database, SIUD, in Brazil. Our next regulatory update discusses the legislation and the associated deadlines in more detail. Of note, a reminder that the technical terms to be used are the GMDN Codes.

EMDN/GMDN Codes

The EUDAMED and Swissdamed databases will use EMDN Codes, while the UK MHRA PARD uses GMDN Codes. 

In addition, the U.S. Food and Drug Administration (FDA) UDI database, GUDID, and the Australia ARTG listings and AusDID, include GMDN Codes, and the forthcoming Brazil SIUD databases will also use GMDN Codes. 

Concluding remarks

The proliferation of regulator device registration and UDI databases signals the era of data transparency. The 2026 year includes important deadlines for parts of EUDAMED, Swissdamed, and Class IIb and Class III devices in AusUDID.

Emergo by UL experts welcome the ever-expanding availability of medical device and UDI registration information. This facilitates manufacturers’ assessment of the competitive regulatory landscape, as well as state of the art.